We have been reading news about COVAXIN administered citizens are not allowed to travel to other countries, The News Facts team dived deep to know the “FACTS” of these rumour mongers intentions. We want our readers to know the facts.
FACTS CHECKER
1. Embassies around the world is yet to talk on Vaccine passport
2. Right now the vaccine passport is your RTPCR showing negative which is been taken just before 72 hours of international travel
3. India’s cumulative vaccination coverage past the 3.07-billion mark on Friday
4. CDC’s website clearly says its RTPCR Negative certificate is must and not insisting on which vaccine you got administered
5. Minister-counsellor for consular affairs in US Embassy New Delhi, Don Heflin, clearly had said many times its RTPCR Negative certificate is must to travel and not any vaccine
Then why is the news getting reported? Who is creating that panic around “COVAXIN®“
The PR machinery of so called group who is spreading the misinformation called The News Facts reporters to write about news that can create panic among international traveller’s, but we report only FACTS. we want our readers to check facts before falling prey to such news mongers.
COVAXIN success is making the fake newsmakers tizzy
The United States has said vaccination is not a “mandatory requirement” for Indian students to travel to the country, a senior official of the Ministry of External Affairs said on Thursday.
Earlier this June, to a question, Official spokesperson Arindam Bagchi said a “constructive solution” should be found to help Indian students returning to attend academic sessions there. The U.S. Embassy here had recently begun processing visas for on-campus education.
“There is no uniformity in the requirements. The U.S. government has clarified that vaccination is not a mandatory requirement for our students to travel. I also understand that there are multiple conversations going on between our students and the universities.”
The Ministry of External Affairs (MEA) spokesperson Arindam Bagchi told reporters on Thursday that any development regarding Covaxin’s Emergency Use Listing (EUL) authorization by the World Health Organisation (WHO) is being closely followed by the government.
Bharat Biotech, the manufacturer of Covaxin, had expressed confidence in getting the UN body’s approval based on “its experience of getting its other vaccines prequalified by WHO”, and that an approval for emergency use listing is expected during July-September. The manufacturer has also claimed that around 90 per cent of the required documents have already been submitted to WHO and the remaining will be sent in July.
COVAXIN®, India’s indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV).
The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech’s BSL-3 (Bio-Safety Level 3) high containment facility.
Hence putting the other side of story. International Travelers your vaccine passport is your RTPCR Negative Certificate and not any particular branded vaccine
